Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Expression of truncated FHIT transcripts in cervical cancers and in normal human cells

Abstract

To analyse FHIT transcription patterns in cervical cancer, a series of primary cervical tumors and normal control samples were studied using RT–PCR. Full length and truncated FHIT transcripts were detectable in all samples tested. Interestingly, the expression of truncated FHIT transcripts by primary epithelial cells in vitro was associated with confluency. The breakpoints of most transcript deletions coincided with genuine splice site sequences, suggesting that they resulted from alternative splicing. These findings demonstrate that truncated FHIT transcripts are commonly detected in both normal and tumor tissues, and suggest that these altered transcripts are not causally related to tumorigenesis in cervical cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Applequist SE, Selg M, Raman C, Jack HM . 1997 Nucleic Acids Res. 25: 814–821

  • Barnes LD, Garrison PN, Siprashvili Z, Guranowski A, Robinson AK, Ingram SW, Croce CM, Ohta M, Huebner K . 1996 Biochemistry 35: 11529–11535

  • Boldog F, Gemmill RM, West J, Robinson M, Robinson L, Li E, Roche J, Todd S, Waggoner B, Lundstrom R, Jacobson J, Mullokandov MR, Klinger H, Drabkin HA . 1997 Hum. Molec. Genet. 6: 193–203

  • Chaudhuri AR, Khan IA, Prasad V, Robinson AK, Ludueña RF, Barnes LD . 1999 J. Biol. Chem. 274: 24378–24382

  • Chu TY, Shen CY, Chiou YS, Lu JJ, Perng CL, Yu MS, Liu HS . 1998 Int. J. Cancer 75: 199–204

  • Cooper TA, Mattox W . 1997 Am. J. Hum. Genet. 61: 259–266

  • Coulter LR, Landree MA, Cooper TA . 1997 Mol. Cell. Biol. 17: 2143–2150

  • Druck T, Berk L, Huebner K . 1998 Oncol. Res. 10: 341–345

  • Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM, Huebner K . 1997 Cancer. Res. 57: 504–512

  • Ferrer M, Lopez-Borges S, Lazo PA . 1999 Mol. Carcinog. 25: 55–63

  • Gayther SA, Barski P, Batley SJ, Li L, de Foy AF, Cohen SN, Ponder BAJ, Caldas C . 1997 Oncogene. 15: 2119–2126

  • Gemmill RM, West JD, Boldog F, Tanaka N, Robison LJ, Smith DI, Li F, Drabkin HA . 1998 Proc. Natl. Acad. Sci. USA 95: 9572–9577

  • Huebner K, Garrison PN, Barnes LD, Croce CM . 1998 Annu. Rev. Genet. 32: 7–31

  • Ji L, Fang B, Yen N, Fong K, Minna JD, Roth JA . 1999 Cancer Res. 59: 3333–3339

  • Julicher K, Marquitan G, Werner N, Bardenheuer W, Vieten L, Brocker F, Topal H, Seeber S, Opalka B, Schutte J . 1999 J. Natl. Cancer Inst. 91: 1563–1568

  • Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ . 1998 Nature 396: 84–88

  • Kohno T, Takayama H, Hamaguchi M, Takano H, Yamaguchi N, Tsuda H, Hirohashi S, Vissing H, Shimizu M, Oshimura M . 1993 Oncogene 8: 1825–1832

  • Larson AA, Kern S, Curtiss S, Gordon R, Cavenee WK, Hampton GM . 1997 Cancer Res. 57: 4082–4090

  • Le Beau MM, Drabkin H, Glover TW, Gemmill R, Rassool FV, McKeithan TW, Smith DI . 1998 Genes Chrom. Cancer 21: 281–289

  • Li L, Li X, Francke U, Cohen SN . 1997 Cell 88: 143–154

  • Lima CD, Klein MG, Weinstein IB, Hendrickson WA . 1996 Proc. Natl. Acad. Sci. USA 93: 5357–5362

  • Mao L . 1998 J. Natl. Cancer Inst. 90: 412–414

  • Mao L, Fan YH, Lotan R, Hong WK . 1996 Cancer Res. 56: 5128–5131

  • Matthews CP . (2000). Ph.D. Thesis University of Washington

  • Matthews CP, Shera KA, McDougall JK . 2000 Proc. Soc. Exp. Biol. Med. 223: 316–321

  • Mitra AB, Murty VV, Li RG, Pratrap M, Luthra UK, Chaganti RS . 1994 Cancer Res. 54: 4481–4487

  • Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T . 1996 Cell 84: 587–597

  • Otterson GA, Xiao GH, Geradts J, Jin F, Chen WD, Niklinska W, Kaye FJ, Yeung RS . 1998 J. Natl. Cancer Inst. 90: 426–432

  • Panagopoulos I, Thelin S, Mertens F, Mitelman F, Aman P . 1997 Genes Chrom. Cancer 19: 215–219

  • Rader JS, Gerhard DS, O'Sullivan MJ, Li Y, Li L, Liapis H, Huettner PC . 1998 Genes Chrom. Cancer 22: 57–65

  • Ramchatesingh J, Zahler AM, Neugebauer KM, Roth MB, Cooper TA . 1995 Mol. Cell. Biol. 15: 4898–4907

  • Reed R, Maniatis T . 1986 Cell 46: 681–690

  • Sambrook J, Fritsch EF, Maniatis T (ed.) . 1989 Molecular Cloning: A Laboratory p.9.1–9.62 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y

  • Sard L, Accornero P, Tornielli S, Delia D, Bunone G, Camigilio M, Colombo MP, Gramegna M, Croce CM, Pierotti MA, Sozzi G . 1999 Proc. Natl. Acad. Sci. USA 96: 8489–8492

  • Segawa T, Sasagawa T, Yamazaki H, Sakaike J, Ishikawa H, Inoue M . 1999 Cancer 85: 2001–2010

  • Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti MA, Croce CM, Huebner K . 1997 Proc. Natl. Acad. Sci. USA 94: 13771–13776

  • Sun Z, Pan J, Bubley G, Balk SP . 1997 Oncogene 15: 3121–3125

  • Sun X, Perlick HA, Dietz HC, Maquat LE . 1998 Proc. Natl. Acad. Sci. USA 95: 10009–10014

  • Tanaka K, Watakabe A, Shimura Y . 1994 Mol. Cell. Biol. 14: 1347–1354

  • van den Berg A, Draaijers TG, Kok K, Timmer T, Van der Veen AY, Veldhuis PM, de Leij L, Gerhartz CD, Naylor SL, Smith DI, Buys CH . 1997 Genes Chrom. Cancer 19: 220–227

  • Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K, Croce CM . 1996 Proc. Natl. Acad. Sci. USA 93: 9770–9775

  • Wang NM, Chang JG . 1999 Int. J. Mol. Med. 3: 491–495

  • White RA, Terry NHA, Meistrich ML, Calkins DP . 1990 Cytometry 11: 314–317

  • Wistuba II, Montellano FD, Milchgrub S, Virmani AK, Behrens C, Chen H, Ahmadian M, Nowak JA, Muller C, Minna JD, Gazdar AF . 1997 Cancer Res. 57: 3154–3158

  • Wu R, Connolly DC, Dunn RL, Cho KR . 2000 J. Natl. Cancer Inst. 92: 338–344

  • Yokota J, Tsukada Y, Nakajima T, Gotoh M, Shimosato Y, Mori N, Tsunokawa Y, Sugimura T, Terada M . 1989 Cancer Res. 49: 3598–3601

  • Zimonjic DB, Druck T, Ohta M, Kastury K, Croce CM, Popescu NC, Huebner K . 1997 Cancer Res. 57: 1166–1170

Download references

Acknowledgements

We thank Jennifer Koop and Hadar Sheffer for their excellent technical assistance, and the presented work was supported by NIH grant CA42792.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C P Matthews.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matthews, C., Shera, K., Kiviat, N. et al. Expression of truncated FHIT transcripts in cervical cancers and in normal human cells. Oncogene 20, 4665–4675 (2001). https://doi.org/10.1038/sj.onc.1204622

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204622

Keywords

This article is cited by

Search

Quick links